数图药讯2012年第18期

《数图药讯2012年第18期》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。

1、目录新药上市...................................................................................1FDA批准Stendra用于男性勃起功能障碍·················································1FDA授予Andromeda公司糖尿病药物DiaPep277罕用药地位···············2Mylan在美推出立普妥仿制药······························

2、······································22012年6月1日Sun医药公司Azelastine鼻用喷雾仿制药获美FDA批准·······················3第18期总第379期审批进展...................................................................................3FDA顾问委员会推荐批准新款减肥药罗卡西林····································

3、···3—出版—EMA建议批准新型囊性纤维化药物Kalydeco··········································4中国医药工业信息中心西班牙Almirall公司COPD药物aclidinium获EMA肯定意见·············5卫材癫痫新药Fycompa获CHMP积极意见··············································5辉瑞Axitinib作为晚期肾癌二线治疗获CHMP肯定意见······················6诺

4、和诺德重组凝血因子XIII获欧盟积极意见···········································7强生HIV药物Prezista高剂量版本上市审批申请遭FDA拒绝·············7利伐沙班用于ACS未通过FDA顾问委员会审评·····································7业界动态...................................................................................8

5、世卫组织：全球非传染性疾病负担日益严重············································8审阅：祝林礼来、诺和诺德、赛诺菲激战糖尿病药物市场········································9编写：邵雯君美编：钱苗苗行业分析.................................................................................10地址：上海市北京西路1320号药用明胶原料价格上涨20%医

6、药行业面临成本压力······························10邮编：200040国际仿制药企业Teva、Mylan、Ranbaxy的分析比较·····························12电话：021-62477965中药注射剂：重拾信任要靠产业升级·······················································14传真：021-62890581本周视点........................................

7、.........................................16信息来源：www.pharmadl.com中医药“十二五”规划出炉·······································································16专利详解.................................................................................18中国医药数字图书馆感谢您一贯Trimeges

8、tone主要相关专利········································································18的支持！掌握医药界的众多变化，请继续关注我们给您带来的精彩及时的药讯快报！数图药讯新药上市FDA批准Stendra用于男性勃起功能障碍2012年4月27日，FDA（包括Stendra），并立刻与医生取得联系。批准治疗男性